Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027869
Filing Date
2023-08-11
Accepted
2023-08-11 17:00:47
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 671023
2 ex31-1.htm EX-31.1 16640
3 ex31-2.htm EX-31.2 17466
4 ex32-1.htm EX-32.1 6689
5 ex32-2.htm EX-32.2 6697
  Complete submission text file 0001493152-23-027869.txt   3429264

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE celc-20230630.xsd EX-101.SCH 24779
7 XBRL CALCULATION FILE celc-20230630_cal.xml EX-101.CAL 42270
8 XBRL DEFINITION FILE celc-20230630_def.xml EX-101.DEF 91848
9 XBRL LABEL FILE celc-20230630_lab.xml EX-101.LAB 243199
10 XBRL PRESENTATION FILE celc-20230630_pre.xml EX-101.PRE 179471
42 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 413808
Mailing Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446
Business Address 16305 36TH AVENUE N SUITE 100 MINNEAPOLIS MN 55446 763-392-0767
Celcuity Inc. (Filer) CIK: 0001603454 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38207 | Film No.: 231165032
SIC: 8071 Services-Medical Laboratories